MEVOL: High Profits in the E-cigarette Industry but Stringent Store Opening Requirements

Jun.04.2023
MEVOL: High Profits in the E-cigarette Industry but Stringent Store Opening Requirements
The Vapexpo in Madrid features interviews with Mevol's Spanish branch manager and highlights the challenges of the Spanish tobacco market.

Special statement:

 

This article is intended for internal research and exchange within the industry, and does not make any recommendations for specific brands or products. Minors are prohibited from accessing this content.

 

On June 4th, the Vapexpo electronic cigarette exhibition in Madrid, Spain entered its second day. The staff of 2FIRSTS London News Center continued to conduct interviews at the exhibition site.

 

Today, 2FIRSTS interviewed Roberto, the manager of Mevol's Spanish branch, which is an electronic cigarette brand owned by Shenzhen Miwo Technology Co., Ltd.

 

Roberto shared his insights on the tobacco market in Spain with 2FIRSTS, revealing the challenges the industry currently faces in the country.

 

International top brands have a first-mover advantage and attract a younger demographic of consumers.

 

According to Roberto, data shows that there are 16,000 tobacco shops across Spain, with approximately half (8,000) showing interest in selling electronic cigarettes. The shops that are not interested are often located in remote or traditional communities, catering mainly to older customers who prefer traditional cigarettes over e-cigarettes, hindering sales of the latter.

 

Therefore, shops willing to sell electronic cigarettes are often located in areas where many young people congregate, making them the main market for electronic cigarette consumption in Spain.

 

He pointed out that small and medium-sized e-cigarette brands face difficulties in promoting themselves in tobacco shops. Most tobacco shops interested in e-cigarettes tend to prioritize stocking the largest brands to reduce their inventory costs. Therefore, well-known brands such as ELFBAR and WAKA, backed by large corporations, are more likely to appear frequently in these stores.

 

The profit margin of electronic cigarettes can reach up to 240%, but the cost of opening a store is high.

 

Furthermore, Roberto emphasized that although every tobacco shop has the same sign, they are not actually chain stores. These shops are independently operated establishments under a government-issued monopoly license. Individuals can only own one tobacco shop, which is equivalent to every citizen in Spain being allowed to register and operate only one tobacco shop.

 

The boom in the Spanish market is set to begin in mid-2022, making the profit margin for e-cigarettes higher than that of traditional cigarettes.

 

The Spanish government has imposed strict limitations on the tobacco market, with a retail profit margin of only 8.5%. Meanwhile, e-cigarette purchasing prices range between 3.5 and 4 euros, but retail prices can reach up to 12 euros.

 

However, the high cost of opening a store cannot be ignored. Mr. Lin, a businessman interviewed by 2FIRSTS, stated that the cost of opening a tobacco store in some busy areas, such as central Madrid, can be very high and may require hundreds of thousands or even millions of euros.

 

The government has set a limit on the number of tobacco licenses that can be issued for each city or area during urban planning. For instance, in the city of Madrid, only 100 tobacco shops are allowed to operate. If someone wishes to open the 101st shop, they must pay the government a fee to obtain a license.

 

Could government regulation become uncertain and be added to the tobacco management system?

 

On June 3rd, Juan, the Spanish representative of Olé, a disposable e-cigarette brand, stated in an interview with 2FIRSTS that Spain's e-cigarette regulations will become increasingly strict, with e-cigarettes potentially being included in the tobacco regulatory system within the next two years.

 

We interviewed other exhibitors on this issue and Avant Smoke representative Zhu Jianxiang, who works for a tobacco import and export company, said that it's unlikely for electronic cigarettes to be included in the tobacco industry. Spain had previously proposed a similar bill, but it did not pass due to political changes.

 

On April 14th, Spain will introduce a royal decree aimed at regulating the manufacturing, display, and marketing of tobacco and related products. The decree includes provisions such as a clear classification of emerging tobacco and related products, the use of neutral packaging, traceability, and safety measures, and a ban on certain additives and ingredients that may be more attractive to consumers.

 

Currently, the decision is in the public consultation stage and still awaits the final decision from the government.

 

Small and medium-sized electronic cigarette brands in Spain are facing multiple challenges in the market, including difficulties in promotion, restrictions on city planning, and negative news related to being included in the tobacco industry.

 

Context:

 

On May 15th, 2FIRSTS and VAPEXPO SPAIN announced a partnership to work together as media partners to advance and promote the development and exchange of the global electronic cigarette industry.

 

Vapexpo Spain, the largest and most important vaporization industry exhibition in Spain, brought together vape manufacturers, suppliers, retailers, and industry experts from around the world. 2FIRSTS, as a global vaporization technology media and think tank, focuses on market and development hot topics in the global vaporization field, and is committed to promoting information exchange in the global e-cigarette industry. Through its media influence, it helps to promote the global development of the vaporization industry.

 

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
Vape Manufacturer Ispire Expands Malaysia Operations, Negotiates Southeast Asia OEM Deal as Nicotine Pouch and US Age-Gating Businesses Develop
US-listed vaping technology and manufacturing company Ispire Technology reported fiscal first-quarter 2027 revenue of $27.5 million on November 9, 2026, down 9.3% year over year but up 3.2% sequentially. Gross margin recovered to 16.2%, while its net loss widened to $6.4 million from $3.3 million a year earlier. Management attributed the sales decline primarily to tighter European vaping regulation and reduced distributor orders. Ispire is expanding manufacturing in Malaysia and negotiating an OEM/ODM agreement with a Southeast Asian vaping brand, with an announcement anticipated in January 2027. The company estimates that Malaysian manufacturing offers an approximately 25% US tariff advantage over China-based production. However, it continues to purchase products from Shenzhen Yi Jia Technology Co., Ltd., a manufacturer controlled by its chairman, and reported $52 million in non-current related-party payables at September 30.
company
Nov.11 by 2Firsts Perspectives
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives